Conversion from sandimmune to neoral in renal transplant recipients: two-year experience

By Wilczek H.E.   &   9kesson P.   Warholm C.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1753-1755

Elsevier

Access to resources Recommend Favorite

Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy

By Waller J.R.   Murphy G.J.   Metcalfe M.S.   Sandford R.M.   Pattenden C.J.   Nicholson M.L.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1587-1588

Elsevier

Access to resources Recommend Favorite

Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study

By Wong K.M.   Cheung C.Y.   Chan Y.H.   Chak W.L.   Choi K.S.   Chau K.F.   Li C.S.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1721-1722

Elsevier

Access to resources Recommend Favorite

Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-neoral

By Nichelle L.   Canet S.   Garrigue V.   Chong G.   Mourad G.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2824-2825

Elsevier

Access to resources Recommend Favorite

A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients

By Charpentier B.   European Tacrolimus vs Microemulsified Cyclosporin Study Group  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1625-1626

Elsevier

Access to resources Recommend Favorite